Enno Spillner (born in 1970, German citizen) joined Evotec as Chief Financial Officer and Member of the Management Board on 18 July 2016. His current term will expire on 17 July 2022. From April 2013 until June 2016 he served as Chairman of the Management Board, Chief Executive Officer (CEO) and Chief Financial Officer (CFO) of 4SC AG. He joined 4SC’s Management Board already in September 2005 as CFO. Before working for 4SC, Enno Spillner was Head of Finance and Controlling at BioM AG, a German regional biotech venture fund, which he joined at the beginning of 1999. In this role he was, besides finance and controlling, responsible for managing investments in the equity portfolio and also held the position of interim Managing Director at two portfolio companies; ACTIPAC Biosystems GmbH and Munich Innovative Biomaterials GmbH. In September 2001, he also assumed the position as Management Partner of BioM VC Fund.
Enno Spillner began his career at MediaPlus Spezialagentur für Media GmbH, Munich. Since 2014, he has been a Non-Executive Member of the Board of Directors and Chairman of the Audit Committee at Nanobiotix SA, Paris. Enno Spillner earned his Dipl.-Kaufmann degree (Masters in Business) at the University of Bamberg, Germany.